Relationship between type 2 diabetes mellitus and hypothalamic-pituitary- adrenal axis

Wiener Klinische Wochenschrift

Volumn 123, Issue 1-2, 2011, Pages 28-33

  Felšöci, Marek ^a   Schroner, Zbyněk ^a   Petrovičová, Jozefína ^b   Lazúrová, Ivica ^a  

^a L PASTEUR UNIVERSITY HOSPITAL   (Slovakia)

^b P J AFÁRIK UNIVERSITY   (Slovakia)

Author keywords

Hypothalamic pituitary adrenal axis; Metabolic syndrome; Subclinical Cushing's syndrome; Subclinical hypercortisolism; Type 2 diabetes mellitus

Indexed keywords

CORTICOTROPIN; DEXAMETHASONE; PRASTERONE SULFATE;

ADRENAL INCIDENTALOMA; ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CUSHING SYNDROME; DEXAMETHASONE SUPPRESSION TEST; DISEASE ASSOCIATION; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LOW DRUG DOSE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE;

ADULT; AGED; AGED, 80 AND OVER; CUSHING SYNDROME; DEHYDROEPIANDROSTERONE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; STATISTICS AS TOPIC;

EID: 79952281771     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-010-1497-8     Document Type: Article

References (39)

1. M Boscaro L Barzon F Fallo N Sonino 2001 Cushing's syndrome Lancet 357 9258 783 791 1:STN:280:DC%2BD3M7pvVGnsA%3D%3D 10.1016/S0140-6736(00)04172-6 11253984 (Pubitemid 32217692)
2. RM Chidiac DC Aron 1997 Incidentalomas. A disease of modern technology Endocrinol Metab Clin North Am 26 1 233 253 1:STN:280:DyaK2s3ivVygtw%3D%3D 10.1016/S0889-8529(05)70242-5 9074861 (Pubitemid 27123903)
3. M Reincke 2000 Subclinical Cushing's syndrome Endocrinol Metab Clin North Am 29 1 43 56 1:STN:280:DC%2BD3c7ps1yisA%3D%3D 10.1016/S0889-8529(05)70115-8 10732263 (Pubitemid 30151888)
4. G Mansmann J Lau E Balk M Rothberg Y Miyachi SR Bornstein 2004 The clinically inapparent adrenal mass: update in diagnosis and management Endocr Rev 25 2 309 340 10.1210/er.2002-0031 15082524 (Pubitemid 38528713)
5. R Rossi L Tauchmanová A Luciano M Di Martino C Battista L del Viscovo, et al. 2000 Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features J Clin Endocrinol Metab 85 4 1440 1448 1:CAS:528:DC%2BD3cXisFOqtbg%3D 10.1210/jc.85.4.1440 10770179 (Pubitemid 32289484)
6. M Terzolo A Pia A Alí G Osella G Reimondo S Bovio, et al. 2002 Adrenal incidentaloma: a new cause of the metabolic syndrome? J Clin Endocrinol Metab 87 3 998 1003 1:CAS:528:DC%2BD38XitlWgs7c%3D 10.1210/jc.87.3.998 11889151 (Pubitemid 36121054)
7. L Tauchmanová R Rossi B Biondi M Pulcrano V Nuzzo EA Palmieri, et al. 2002 Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk J Clin Endocrinol Metab 87 10 4872 4878 10.1210/jc.2001-011766 12414841 (Pubitemid 35316318)
8. M Terzolo G Reimondo S Bovio A Angeli 2004 Subclinical Cushing's syndrome Pituitary 7 4 217 223 10.1007/s11102-005-4024-6 16132200 (Pubitemid 43115856)
9. M Torlontano I Chiodini M Pileri G Guglielmi M Cammisa M Modoni, et al. 1999 Altered bone mass and turnover in female patients with adrenal incidentaloma: the effect of subclinical hypercortisolism J Clin Endocrinol Metab 84 7 2381 2385 1:CAS:528:DyaK1MXks1agtbo%3D 10.1210/jc.84.7.2381 10404807
10. I Chiodini M Torlontano V Carnevale G Guglielmi M Cammisa V Trischitta, et al. 2001 Bone loss rate in adrenal incidentalomas: a longitudinal study J Clin Endocrinol Metab 86 11 5337 5341 1:CAS:528:DC%2BD3MXos1Kqsb0%3D 10.1210/jc.86.11.5337 11701701 (Pubitemid 33070256)
11. L Tauchmanová R Rossi V Nuzzo A del Puente A Esposito-del Puente C Pizzi, et al. 2001 Bone loss determined by quantitative ultrasonometry correlates inversely with disease activity in patients with endogenous glucocorticoid excess due adrenal mass Eur J Endocrinol 145 3 241 247 10.1530/eje.0.1450241 11517003 (Pubitemid 32825656)
12. NIH State-of-the-Science Statement on management of the clinically inapparent adrenal mass ("incidentaloma"). NIH Consens State Sci Statements. 2002;19(2):1-23
13. G Reimondo A Pia B Allasino F Tassone S Bovio G Boretta, et al. 2007 Screening of Cushing's syndrome in adult patients with newly diagnosed diabetes mellitus Clin Endocrinol 67 2 225 229 1:CAS:528:DC%2BD2sXpslOgu7k%3D 10.1111/j.1365-2265.2007.02865.x (Pubitemid 47076296)
14. N Valli B Catargi N Ronci V Vergnot F Leccia JM Ferriere, et al. 2001 Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentalomas Eur J Endocrinol 144 4 401 408 1:CAS:528: DC%2BD3MXjsVaju7s%3D 10.1530/eje.0.1440401 11275951 (Pubitemid 32409594)
15. B Catargi V Rigalleuau A Poussin N Ronci-Chaix V Bex V Vergnot, et al. 2003 Occult Cushing's syndrome in type-2 diabetes J Clin Endocrinol Metab 88 12 5808 5813 1:CAS:528:DC%2BD3sXhtVSgsr3P 10.1210/jc.2003-030254 14671173 (Pubitemid 38033055)
16. I Chiodini G Adda A Scillitani F Coletti V Morelli S Di Lembo, et al. 2007 Cortisol secretion in patients with type 2 diabetes: relationship with chronic complications Diabetes Care 30 1 83 88 1:CAS:528:DC%2BD2sXhsFWqtLc%3D 10.2337/dc06-1267 17192338 (Pubitemid 46052503)
17. G Leibowitz A Tsur SD Chayen M Salameh I Raz E Cerasi, et al. 1996 Pre-clinical Cushing's syndrome: an unexpected frequent cause of poor glycemic control in obese diabetic patients Clin Endocrinol 44 6 717 722 1:STN:280:DyaK28zjs1Witg%3D%3D 10.1046/j.1365-2265.1996.737558.x (Pubitemid 26225189)
18. LN Contreras E Cardoso MP Lozano J Pozzo P Pagano H Claus-Hermerg 2000 Detection of preclinical Cushing's syndrome in overweight type 2 diabetic patients Medicina (B Aires) 60 3 326 330 1:STN:280:DC%2BD3crgtlejsg%3D%3D
19. I Chiodini M Torlontano A Scillitani M Arosio S Bacci S Di Lembo, et al. 2005 Association of subclinical hypercortisolism with type 2 diabetes mellitus: a case control study in hospitalized patients Eur J Endocrinol 153 6 837 844 1:CAS:528:DC%2BD28XjtVWmtw%3D%3D 10.1530/eje.1.02045 16322389 (Pubitemid 43020234)
20. MS Caetano C Silva Rdo CE Kater 2007 Increased diagnostic probability of subclinical Cushing's syndrome in a population sample of overweight adult patients with type 2 diabetes mellitus Arq Bras Endocrinol Metabol 51 7 1118 1127 18157388
21. T Taniguchi A Hamasaki M Okamoto 2008 Subclinical hypercortisolism in hospitalized patients with type 2 diabetes mellitus Endocr J 55 2 429 432 1:CAS:528:DC%2BD1cXos1ylt7k%3D 10.1507/endocrj.K07E-045 18362453 (Pubitemid 351670972)
22. S Newsome K Chen J Hoang JD Wilson JM Potter PE Hickman 2008 Cushing's syndrome in a clinic population with diabetes Intern Med J 38 3 178 182 1:STN:280:DC%2BD1c7jtVejsQ%3D%3D 10.1111/j.1445-5994.2007.01434.x 17645502 (Pubitemid 351271400)
23. JE Nestler MA McClanahan NJ Clore WG Blackard 1992 Insulin inhibits adrenal 17,20-lyase activity in man J Clin Endocrinol Metab 74 2 362 367 1:CAS:528:DyaK38Xit1yltL8%3D 10.1210/jc.74.2.362 1730815
24. JE Nestler KS Usiskin CO Barlascini DF Welty JN Clore WG Blackard 1989 Supression of serum dehydroepiandrosterone sulfate levels by insulin: an evaluation of a possible mechanism J Clin Endocrinol Metab 69 5 1040 1046 1:CAS:528:DyaL1MXmt1Gltbc%3D 10.1210/jcem-69-5-1040 2529264 (Pubitemid 19261836)
25. M Maccario E Mazza J Ramunni SE Oleandri P Savio S Grottoli, et al. 1999 Relationship between dehydroepiandrosterone-sulphate and anthropometric, metabolic and hormonal variables in a large cohort of obese women Clin Endocrinol 50 5 595 600 1:STN:280:DyaK1MvgsFWjtA%3D%3D 10.1046/j.1365-2265.1999. 00692.x (Pubitemid 29236336)
26. E Mazza Maccario J Ramunni C Gauna A Bertagna AM Barberis, et al. 1999 Dehydroepiandrosterone sulfate levels in women. Relationship with age, body mass index and insulin levels J Endocrinol Invest 22 9 681 687 1:CAS:528: DyaK1MXnsFSmsbg%3D 10595831 (Pubitemid 29509356)
27. M Muller DE Grobbee I den Tonkelaar SWJ Lamberts YT van der Schouw 2005 Endogenous sex hormones and metabolic syndrome in aging male J Clin Endocrinol Metab 90 5 2618 2623 1:CAS:528:DC%2BD2MXkt1WgsL4%3D 10.1210/jc.2004-1158 15687322 (Pubitemid 40686299)
28. D Mino D Amato ML Cuevas ME Fonseca G Búrbano N Wacher, et al. 2002 Relationship of insulin resistance and overweight with cortisol and dehydroepiandrosterone-sulfate levels Arch Med Res 33 6 524 530 1:CAS:528:DC%2BD38Xps12ms7s%3D 10.1016/S0188-4409(02)00400-9 12505096 (Pubitemid 36026608)
29. RN Al-Harithy 2003 Dehydroepiandrosterone sulfate levels in women. Relationship with body mass index, insulin and glucose levels Saudi Med J 24 8 837 841 12939667 (Pubitemid 37160626)
30. E Barret-Connor A Ferrara 1996 Dehydroepiandrosterone, dehydroepiandrosterone sulfate, obesity, waist-hip ratio, and noninsulin-dependent diabetes in postmenopausal women: the Rancho Bernardo Study J Clin Endocrinol Metab 81 1 59 64 10.1210/jc.81.1.59 (Pubitemid 26035004)
31. M Saruç H Yüceyar S Ayhan N Türkel I Tuzcuoglu M Can 2003 The association of dehydroepiandrosterone, obesity, waist-hip ratio and insulin resistance with fatty liver in postmenopausal women - a hyperinsulinemic euglycemic insulin clamp study Hepatogastroenterology 50 51 771 774 12828082 (Pubitemid 36613402)
32. DL Coleman EH Leiter RW Schwitzer 1982 Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice Diabetes 31 9 830 833 1:CAS:528:DyaL38XlsFKktL0%3D 10.2337/diabetes.31.9.830 6219024 (Pubitemid 12062875)
33. CD Berdanier JA Parente Jr MK McIntosh 1993 Is dehydroepiandrosterone an antiobesity agent? FASEB J 7 5 414 419 1:CAS:528:DyaK3sXitVGgsbo%3D 8462783 (Pubitemid 23108555)
34. A Lasco N Frisina N Morabito A Gaudio E Morini A Trifiletti, et al. 2001 Metabolic effect of dehydroepiandrosterone replacement therapy in postmenopausal women Eur J Endocrinol 145 4 457 461 1:CAS:528:DC%2BD3MXns1Gju7g%3D 10.1530/eje.0.1450457 11581005 (Pubitemid 32927074)
35. MD Villareal JO Holloszy 2004 Effect of DHEA on abdominal fat and insulin action in elderly women and men. A randomized controlled trial JAMA 292 18 2243 2248 1:CAS:528:DC%2BD2cXpvVWms7c%3D 10.1001/jama.292.18.2243 15536111 (Pubitemid 39473162)
36. M Rabijewski W Zgliczynski 2005 Positive effects of DHEA therapy on insulin resistance and lipids in men with angiographically verified coronary heart disease - preliminary study Endokrynol Pol 56 6 904 910 16821209
37. JW Tomlinson EA Walker IJ Bujalska N Draper GG Lavery MS Cooper, et al. 2004 11β-hydroxysteroid dehydrogenase type 1: a tissue specific regulator of glucocorticoid response Endocr Rev 25 5 831 836 1:CAS:528:DC%2BD2cXhtVSjtrnJ 10.1210/er.2003-0031 15466942 (Pubitemid 39366049)
38. N Draper PM Stewar 2005 11β-hydroxysteroid dehydrogenase and the prereceptor regulation of corticosteroid hormone action J Endocrinol 186 251 271 1:CAS:528:DC%2BD2MXpsFagsL8%3D 10.1677/joe.1.06019 16079253 (Pubitemid 41167396)
39. PM Stewart 2005 Tissue-specific Cushing's syndrome uncovers a new target in treating the metabolit syndrome: 11β-hydroxysteroid dehydrogenase type 1 Clin Med 5 126 146